or Try an Advanced Search...

    Technical Analysis for INTS - Intensity Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 4.83 9.28% 0.41
    INTS closed up 9.28 percent on Wednesday, May 15, 2024, on 1.64 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical INTS trend table...
    Date Alert Name Type % Chg
    Crossed Above 200 DMA Bullish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze + Upper Band Touch Range Contraction 0.00%
    Above Upper BB Strength 0.00%
    Gapped Up Strength 0.00%
    200 DMA Resistance Bearish 9.28%
    50 DMA Resistance Bearish 9.28%
    Pocket Pivot Bullish Swing Setup 9.28%
    Older End-of-Day Signals for INTS ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 50 DMA about 22 hours ago
    200 DMA Resistance about 22 hours ago
    1.5x Volume Pace about 22 hours ago
    Up 5% about 22 hours ago
    Up 3% about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    INTS Chart by TradingView
    Basic chart:

    Profile

    intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company’s technology and products.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Pharmacy Chemotherapy

    Is INTS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 2 Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024
    Mar 26 Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
    Mar 14 Intensity Therapeutics GAAP EPS of -$1.38
    Mar 14 Intensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
    Mar 14 Intensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024
    Feb 21 Intensity Therapeutics to Present at the 2024 BIO CEO & Investor Conference
    Jan 3 Intensity Therapeutics Provides Business Update Reflecting Progress in Phase 3 Sarcoma Program
    Jan 2 Intensity Therapeutics: Big Promises, Some Early Data, Low Expense, Low Cash
    Dec 29 Intensity Therapeutics (NASDAQ:INTS) Is In A Good Position To Deliver On Growth Plans
    Dec 14 Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
    See more INTS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.44
    52 Week Low 2.03
    Average Volume 26,914
    200-Day Moving Average 4.62
    50-Day Moving Average 4.47
    20-Day Moving Average 3.97
    10-Day Moving Average 4.01
    Average True Range 0.33
    RSI (14) 66.89
    ADX 22.17
    +DI 29.52
    -DI 12.17
    Chandelier Exit (Long, 3 ATRs) 3.89
    Chandelier Exit (Short, 3 ATRs) 4.53
    Upper Bollinger Bands 4.47
    Lower Bollinger Band 3.48
    Percent B (%b) 1.37
    BandWidth 24.86
    MACD Line -0.02
    MACD Signal Line -0.13
    MACD Histogram 0.1109
    Fundamentals Value
    Market Cap 66.22 Million
    Num Shares 13.7 Million
    EPS -0.74
    Price-to-Earnings (P/E) Ratio -6.53
    Price-to-Sales 0.00
    Price-to-Book 3.07
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.39
    Resistance 3 (R3) 5.34 5.10 5.29
    Resistance 2 (R2) 5.10 4.96 5.13 5.26
    Resistance 1 (R1) 4.97 4.87 5.04 5.02 5.23
    Pivot Point 4.73 4.73 4.77 4.76 4.73
    Support 1 (S1) 4.60 4.59 4.67 4.65 4.43
    Support 2 (S2) 4.36 4.50 4.39 4.40
    Support 3 (S3) 4.23 4.36 4.37
    Support 4 (S4) 4.28